Lingling Xu
机构:Emory University, Shanghai Business School, Zhejiang University of Science and Technology, Guizhou University, Dalian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health and Family Planning Commission, Wenzhou Medical University, Peking Union Medical College Hospital, Quzhou City People's Hospital, Second Affiliated Hospital of Dalian Medical University, Xi’an University, Guangzhou First People's Hospital, Quzhou University, Children's Healthcare of Atlanta, Institute of Hematology & Blood Diseases Hospital, Guizhou Institute of Technology, First Affiliated Hospital of Jinan University, Zhejiang University of Technology, Guangzhou Medical University · ORCID:0000-0003-1341-4141
发表论文 109 篇 · 总被引 1566 次 · h-index 19
代表论文
- The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study (2024 · Renal Failure · 被引 19)
- Global research trends in inflammaging from 2005 to 2024: a bibliometric analysis (2025 · Frontiers in Aging · 被引 7)
- Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials (2024 · World Journal of Diabetes · 被引 5)
- Withaferin A combined with ricolinostat: a potent synergistic therapy for cervical cancer through regulating p53 ubiquitination and acetylation (2025 · Acta Biochimica et Biophysica Sinica · 被引 4)
- The necessity of strengthening glycemic and lipid metabolism management for improving brain structure and cognitive function in people with diabetes: A retrospective study based on UK Biobank (2025 · Diabetes Research and Clinical Practice · 被引 3)
- FcγRI is the key determinant of antibody-mediated Zika virus infection of human placental macrophages (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)